Suppr超能文献

在亚洲人中,肛管腺癌可能会伪装成慢性肛瘘。

Anal Adenocarcinoma Can Masquerade as Chronic Anal Fistula in Asians.

作者信息

Leong Faith Qi-Hui, Chan Dedrick Kok Hong, Tan Ker-Kan

机构信息

Division of Colorectal Surgery, University Surgical Cluster, National University Health System, Singapore.

出版信息

Ann Coloproctol. 2019 Feb;35(1):47-49. doi: 10.3393/ac.2018.03.15. Epub 2018 Dec 3.

Abstract

PURPOSE

Perianal adenocarcinoma arising from a chronic anorectal fistula is a rare condition for which the natural history and optimal management are not well established. For that reason, we conducted a retrospective analysis of 5 consecutive patients with a perianal adenocarcinoma arising from a chronic anorectal fistula managed at our institution from January 2014 to December 2015.

METHODS

The patients were identified from a prospectively collected colorectal cancer database that included all patients managed for colorectal cancer at our institution.

RESULTS

The median age at diagnosis was 64 years (range, 55-72 years). Magnetic resonance imaging (MRI) was the initial investigation for all patients and showed a hyperintense T2-weighted image. One patient underwent an abdominoperineal resection following neoadjuvant chemoradiotherapy and remained disease free during the 12-month follow-up. Three patients received neoadjuvant therapy with intent for surgery, but did not undergo surgery due to either worsening health or metastatic spread. One patient declined intervention. The median overall survival was 10.5 months (range, 2-19 months).

CONCLUSION

A high index of suspicion is required to make a clinical diagnosis of an anal adenocarcinoma arising from a chronic fistula. Histologic diagnosis must be achieved to confirm the diagnosis. Multimodal therapy with neoadjuvant chemoradiotherapy followed by abdominoperineal resection is the treatment of choice.

摘要

目的

源自慢性肛肠瘘的肛周腺癌是一种罕见疾病,其自然史和最佳治疗方案尚未明确。因此,我们对2014年1月至2015年12月在我院接受治疗的5例源自慢性肛肠瘘的肛周腺癌患者进行了回顾性分析。

方法

这些患者是从一个前瞻性收集的结直肠癌数据库中识别出来的,该数据库包含了在我院接受结直肠癌治疗的所有患者。

结果

诊断时的中位年龄为64岁(范围55 - 72岁)。磁共振成像(MRI)是所有患者的初始检查,显示T2加权图像呈高信号。1例患者在新辅助放化疗后接受了腹会阴联合切除术,在12个月的随访期间无疾病复发。3例患者接受了旨在手术的新辅助治疗,但由于健康状况恶化或发生转移而未接受手术。1例患者拒绝干预。中位总生存期为10.5个月(范围2 - 19个月)。

结论

对于源自慢性瘘管的肛管腺癌进行临床诊断需要高度怀疑。必须进行组织学诊断以确诊。新辅助放化疗后行腹会阴联合切除术的多模式治疗是首选治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e4/6425245/df4b164cfaad/ac-2018-03-15f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验